Emergency department of fattouma bourguiba university hospital
Monastir, 5020, Tunisia
NCT Number: NCT04484298
the study aimed to evaluate the diagnostic performance of cardiac output (CO) change after the use of trinitrine in the diagnosis of heart failure patients with acute dyspnea.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Monastir, 5020, Tunisia
Acute heart failure (AHF) is a frequent condition in emergency department and is responsible of high number of admissions, complications, and deaths.
despite advances in diagnostic techniques, AHF diagnosis still be challenging .
Measurement of cardiac output (CO) is used to evaluate global cardiac function and changes in CO may be used to identify a change in the hemodynamic status of patient.
the gold standard of measuring CO is thermodilution catheterization, however it is an invasive technique with high risks.
Impedance cardiography (ICG) is a noninvasive method for measuring CO. it is performed by applying small electrical current to the chest through electrodes placed on the neck and sides.
the pulsatile flow of blood causes fluctuations in the current, and the device calculates CO from the impedance waveform.
In practice, the investigators connect the device "BIOPAC" by using four electrodes which the investigators place on the base of the neck (posterior face) and on the base of the thorax (posterior face).
The ECG recording is taken simultaneously with two other electrodes placed at the right upper limb and left lower limb.
In addition to detecting the electric current and the ECG, heart sounds are recorded using a sensor that is placed at the mitral site.
Each patient is initially placed in a semi-sitting position at 30° for 5 minutes and then CO is measured (baseline CO). NTG (0.6 mg) is then given to the patient sublingually and CO measurement was repeated. CO is calculated by averaging three measurements at one minute intervals at baseline and after NTG administration. DeltaCO was defined as the percent of change of baseline CO after NTG test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient is initially placed in a semi-sitting position at 30° for 5 minutes and then CO is measured (baseline CO)
0.6 mg of Nitroglycerin was administered by sublingual root and CO was evaluated.
Time frame: 24 hours
the diagnostic performance is evaluated by calculating the CO in ml/min by bio-impedance technique and compare the values between patients with and without AHF and between baseline.
Time frame: 24
Receiver operating characteristic (ROC) curves for predicting HF were constructed and area under curve (AUC) was measured for the deltaCO.
Time frame: 24 hours
Sensitivity, specificity, positive and negative predictive values, and likelihood ratios of positive and negative results were calculated using the optimal cutoff value of deltaCO.
University of Monastir
Other
Dynamic Variation of Impedance Cardiography (ICG) a Diagnostic Tool of Acute Heart Failure (AHF) in Emergency Department (ED) Patients Admitted for Acute Dyspnea
Acronym: dyvic2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04999995
Cardiovascular Diseases, Dyspnea
Columbia, South Carolina, United States
View Trial DetailsNCT05964738
Cardiovascular Diseases, Dyspnea
Córdoba, Córdoba (Andalucía), Spain
View Trial DetailsNCT06039397
Arrhythmias, Cardiac, Arrythmia
Jakarta, West Jakarta, Indonesia
View Trial DetailsNCT02835963
Cardiovascular Diseases, Dyspnea
Bordeaux, France
View Trial Details